Arbutus Biopharma Corporation
ABUS
$3.14
$0.020.64%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.62M | 127.79M | 141.99M | 129.24M | 126.00M |
| Total Receivables | 2.71M | 1.91M | 2.07M | 2.74M | 2.38M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.98M | 3.08M | 4.17M | 3.89M | 3.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 127.32M | 132.78M | 148.22M | 135.87M | 132.03M |
|
|
|||||
| Total Current Assets | 127.32M | 132.78M | 148.22M | 135.87M | 132.03M |
| Net Property, Plant & Equipment | 4.36M | 4.70M | 5.30M | 5.74M | 6.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 34.00K | -- | -- | -- | -- |
| Total Assets | 131.71M | 140.44M | 160.04M | 150.29M | 144.40M |
|
|
|||||
| Total Accounts Payable | 2.32M | 2.32M | 2.65M | 3.74M | 3.22M |
| Total Accrued Expenses | 5.25M | 4.66M | 8.46M | 4.50M | 7.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 483.00K | 468.00K | 453.00K | 502.00K | 425.00K |
| Total Finance Division Other Current Liabilities | 7.57M | 11.48M | 11.03M | 11.55M | 11.79M |
| Total Other Current Liabilities | 7.57M | 11.48M | 11.03M | 11.55M | 11.79M |
| Total Current Liabilities | 15.62M | 18.92M | 22.60M | 20.30M | 22.49M |
|
|
|||||
| Total Current Liabilities | 15.62M | 18.92M | 22.60M | 20.30M | 22.49M |
| Long-Term Debt | 4.83M | 5.32M | 5.86M | 6.40M | 6.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 806.00K | 978.00K | 1.14M | 1.18M | 1.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.09M | 8.34M | 7.99M | 7.78M | 7.60M |
| Total Liabilities | 34.34M | 33.55M | 37.59M | 35.65M | 38.38M |
|
|
|||||
| Common Stock & APIC | 1.49B | 1.49B | 1.49B | 1.46B | 1.43B |
| Retained Earnings | -1.35B | -1.33B | -1.31B | -1.29B | -1.28B |
| Treasury Stock & Other | -48.14M | -48.09M | -48.31M | -48.37M | -48.42M |
| Total Common Equity | 97.37M | 106.89M | 122.45M | 114.64M | 106.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 97.37M | 106.89M | 122.45M | 114.64M | 106.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 97.37M | 106.89M | 122.45M | 114.64M | 106.02M |
|
|
|||||
